# | Filing Date | Period End Date | Type | Report Link |
---|---|---|---|---|
No Data found |
# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Canaccord Genuity analyst Matt Bottomley maintains Aurora Cannabis (TSX:ACB) with a Buy and raises the price target from C$8...
Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB) announced on Thursday its financial and operational results for the fourth quarte...
Slightly over a year following Gov. Dan McKee's decision to appoint three experts to the Cannabis Control Commission with a...
Flora Growth Corp. has entered into a definitive agreement to acquire all of the issued and outstanding shares of Hamburg, Germ...
German legalization will one of the many hot topics at the Benzinga Cannabis Capital Conference in Florida on April 16-17.
Aurora Cannabis said on Wednesday that it has obtained Good Manufacturing Practice (GMP) certification from Australia's The...
Canada's Leading Medical Cannabis Company and MedReleaf Australia Launch Innovative Product to Offer Greater Choice for Pat...
Aurora Cannabis has repaid its convertible senior notes, marking a significant milestone as it nears financial recovery. With r...